Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Precancerous Conditions 8Lymphoma 8Leukemia, Myeloid, Acute 8Leukemia, Lymphocytic, Chronic, B-Cell 8Leukemia 8Myelodysplastic Syndromes 7Neoplasms, Plasma Cell 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myeloid, Accelerated Phase 6Hodgkin Disease 6Congenital Abnormalities 6Burkitt Lymphoma 6Primary Myelofibrosis 5Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Biphenotypic, Acute 4

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × fludarabine phosphate × Other neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡